Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
9.00
-0.03 (-0.33%)
Mar 31, 2025, 2:27 PM EDT - Market open
Bioventus Employees
Bioventus had 930 employees as of December 31, 2024. The number of employees decreased by 40 or -4.12% compared to the previous year.
Employees
930
Change (1Y)
-40
Growth (1Y)
-4.12%
Revenue / Employee
$616,430
Profits / Employee
-$36,067
Market Cap
595.41M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BVS News
- 19 days ago - Bioventus Inc. (BVS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Medical Device Firm Bioventus Stock Jumps On Upbeat 2025 Outlook, Cuts Debt By $48 Million - Benzinga
- 20 days ago - Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 4 weeks ago - Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 - GlobeNewsWire
- 3 months ago - Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners - GlobeNewsWire
- 5 months ago - Bioventus Inc. (BVS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Bioventus Reports Third Quarter Financial Results - GlobeNewsWire
- 5 months ago - Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 - GlobeNewsWire